Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)
Sensus Healthcare's quarterly Cash from Financing Activities came in at -$5000.0 in Q4 2025, down 117.86% year-on-year from $28000.0 in Q4 2024, and up 98.33% quarter-over-quarter from -$300000.0 in Q1 2025.
Sensus Healthcare has reported Cash from Financing Activities for 9 years, with the latest figure at -$5000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities fell 117.86% year-over-year to -$5000.0; the trailing twelve-month figure through Dec 2025 stood at -$305000.0 (down 535.42% YoY), and the FY2025 full-year result was -$305000.0, down 2133.33% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$5000.0, up from -$300000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $273000.0 in Q1 2022, with the low at -$1.9 million in Q4 2022.
- Average Cash from Financing Activities over 5 years is -$200400.0, with a median of -$39000.0 recorded in 2023.
- Peak annual rise in Cash from Financing Activities reached 555.0% in 2022, while the deepest fall reached 3481.48% in 2022.
- Tracing SRTS's Cash from Financing Activities over 5 years: stood at -$54000.0 in 2021, then plunged by 3481.48% to -$1.9 million in 2022, then soared by 99.64% to -$7000.0 in 2023, then surged by 500.0% to $28000.0 in 2024, then sank by 117.86% to -$5000.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$5000.0 (Q4 2025), -$300000.0 (Q1 2025), and $28000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | -1.93 Mn |
| Dec 31, 2022 | -1.93 Mn |
| Sep 30, 2022 | 211,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | -978,000.00 |
| Jun 30, 2022 | -978,000.00 |
| Mar 31, 2022 | 273,000.00 |
| Mar 31, 2022 | 273,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | -63,000.00 |
| Sep 30, 2021 | -63,000.00 |
| Jun 30, 2021 | -54,000.00 |
| Jun 30, 2021 | -54,000.00 |
| Mar 31, 2021 | -60,000.00 |
| Mar 31, 2021 | -60,000.00 |
| Dec 31, 2020 | -756,000.00 |
| Dec 31, 2020 | -756,000.00 |
| Jun 30, 2020 | 970,000.00 |
| Jun 30, 2020 | 970,000.00 |
| Mar 31, 2020 | -3,000.00 |
| Mar 31, 2020 | -3,000.00 |
| Jun 30, 2019 | -81,413.00 |
| Jun 30, 2019 | -81,413.00 |
| Mar 31, 2019 | 2.70 Mn |
| Mar 31, 2019 | 2.70 Mn |
| Sep 30, 2018 | 11.64 Mn |
| Sep 30, 2018 | 11.64 Mn |
| Jun 30, 2018 | -122,219.00 |
| Jun 30, 2018 | -122,219.00 |
| Mar 31, 2018 | 2.09 Mn |
| Mar 31, 2018 | 2.09 Mn |
| Dec 31, 2017 | 589,000.00 |
| Dec 31, 2017 | 589,000.00 |
| Sep 30, 2017 | 177,999.00 |
| Sep 30, 2017 | 177,999.00 |
| Jun 30, 2017 | -185,847.00 |
| Jun 30, 2017 | -185,847.00 |
| Mar 31, 2017 | 1.34 Mn |
| Mar 31, 2017 | 1.34 Mn |